Pharmaceuticals

* BASF, Europe’s biggest chemical manufacturer, is considering bids of at least $6 billion for its Knoll drug unit, people familiar with the situation said. Analysts said bidders, which could include Bristol-Myers Squibb Co. and Eli Lilly & Co., are said to attracted to Knoll’s rheumatoid arthritis drug D2E7.